Setback for Medtronic in ongoing patent dispute with Johnson & Johnson
This article was originally published in Clinica
The US Supreme Court refused to hear Medtronic's appeal over a patent infringement ruling in favour of Johnson & Johnson on February 23. At stake is $271.1m in damages that, as it stands, Medtronic is required to pay to its rival. However, the Supreme Court's decision does not conclude the dispute, and the case is to be reviewed in a district court next month.